Delong Mark Jeffrey Insider Trades

Insider Trading History

Track insider trading activity for Delong Mark Jeffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.38M 82,500 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 82,500 shares
$19.39
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.44M 83,945 shares
Last Trade
Feb 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.4k 363 shares
$28.54
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.46M 84,308 shares
Last Trade
Jan 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.8k 365 shares
$29.52
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.47M 84,673 shares
Last Trade
Jan 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.5k 1,396 shares
$30.43
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.53M 86,069 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$859k 28,508 shares
$30.13
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.36M 57,561 shares
Last Trade
Jan 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$37k 1,235 shares
$29.96
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.41M 58,796 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$45.9k 1,599 shares
$28.70
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.48M 60,395 shares
Last Trade
Aug 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 5,201 shares
$36.16
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $607k 14,799 shares
Last Trade
Aug 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 5,201 shares
$36.16
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.24M 54,693 shares
Last Trade
Mar 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$564k 9,913 shares
$56.90
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.65M 64,606 shares
Last Trade
Feb 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.5k 597 shares
$67.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.68M 65,203 shares
Last Trade
Jan 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.5k 367 shares
$64.14
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.69M 65,570 shares
Last Trade
Jan 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$90k 1,384 shares
$65.00
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.81M 68,585 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.64M 24,666 shares
$66.30
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.75M 66,954 shares
Last Trade
Jan 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 1,631 shares
$66.81
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.12M 51,622 shares
Last Trade
Oct 23, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.03k 131 shares
$46.04
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.11M 51,341 shares
Last Trade
Feb 21, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.8k 441 shares
$58.50
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $2.12M 51,782 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$438k 7,489 shares
$58.50
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $1.91M 46,502 shares
Last Trade
Feb 10, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.3k 670 shares
$51.21
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $1.94M 47,172 shares
Last Trade
Jan 27, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.4k 367 shares
$52.77
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up